Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Cell Reprogramming Market, by Region, 2020-2028 (USD Million)
1.2.2. Cell Reprogramming Market, by Technology, 2020-2028 (USD Million)
1.2.3. Cell Reprogramming Market, by Application, 2020-2028 (USD Million)
1.2.4. Cell Reprogramming Market, by End-User, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell Reprogramming Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years onsidered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell Reprogramming Market Dynamics
3.1. Cell Reprogramming Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing industry attention on cell reprogramming
3.1.1.2. Growing acceptance of cell reprogramming in cancer research
3.1.2. Market Challenges
3.1.2.1. Ethical concerns related to embryonic stem cells
3.1.2.2. limited awareness regarding treatment options
3.1.3. Market Opportunities
3.1.3.1. High priority on partnerships and collaborations
Chapter 4. Global Cell Reprogramming Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cell Reprogramming Market, by Technology
6.1. Market Snapshot
6.2. Global Cell Reprogramming Market by Technology, Performance - Potential Analysis
6.3. Global Cell Reprogramming Market Estimates & Forecasts by Technology, 2018-2028 (USD Million)
6.4. Cell Reprogramming Market, Sub Segment Analysis
6.4.1. Sendai Virus-based Reprogramming
6.4.2. mRNA Reprogramming
6.4.3. Episomal Reprogramming
6.4.4. Others
Chapter 7. Global Cell Reprogramming Market, by Application
7.1. Market Snapshot
7.2. Global Cell Reprogramming Market by Application, Performance - Potential Analysis
7.3. Global Cell Reprogramming Market Estimates & Forecasts by Application, 2018-2028 (USD Million)
7.4. Cell Reprogramming Market, Sub Segment Analysis
7.4.1. Research
7.4.2. Therapeutic
Chapter 8. Global Cell Reprogramming Market, by End-User
8.1. Market Snapshot
8.2. Global Cell Reprogramming Market by End-User, Performance - Potential Analysis
8.3. Global Cell Reprogramming Market Estimates & Forecasts by End-User, 2018-2028 (USD Million)
8.4. Cell Reprogramming Market, Sub Segment Analysis
8.4.1. Research & Academic Institutes
8.4.2. Biotechnology & Pharmaceutical Companies
8.4.3. Hospitals & Clinics
Chapter 9. Global Cell Reprogramming Market, Regional Analysis
9.1. Cell Reprogramming Market, Regional Market Snapshot
9.2. North America Cell Reprogramming Market
9.2.1. U.S. Cell Reprogramming Market
9.2.1.1. Technology breakdown estimates & forecasts, 2018-2028
9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-User breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Cell Reprogramming Market
9.3. Europe Cell Reprogramming Market Snapshot
9.3.1. U.K. Cell Reprogramming Market
9.3.2. Germany Cell Reprogramming Market
9.3.3. France Cell Reprogramming Market
9.3.4. Spain Cell Reprogramming Market
9.3.5. Italy Cell Reprogramming Market
9.3.6. Rest of Europe Cell Reprogrammidng Market
9.4. Asia-Pacific Cell Reprogramming Market Snapshot
9.4.1. China Cell Reprogramming Markket
9.4.2. India Cell Reprogramming Market
9.4.3. Japan Cell Reprogramming Market
9.4.4. Australia Cell Reprogramming Market
9.4.5. South Korea Cell Reprogramming Market
9.4.6. Rest of Asia Pacific Cell Reprogramming Market
9.5. Latin America Cell Reprogramming Market Snapshot
9.5.1. Brazil Cell Reprogramming Market
9.5.2. Mexico Cell Reprogramming Market
9.6. Rest of The World Cell Reprogramming Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategiesd
10.2. Company Profiles
10.2.1. Allele biotechnology
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Alstem
10.2.3. Applied biological materials
10.2.4. Axol bioscience
10.2.5. Creative bioarray
10.2.6. Definigen
10.2.7. Fujifilm cellular dynamics
10.2.8. Lonza
10.2.9. Mogrify
10.2.10. Reprocell
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption